Interaction between Hepatitis B Virus and Toll-Like Receptors: Current Status and Potential Therapeutic Use for Chronic Hepatitis B
Immune defense against infection with the hepatitis B virus (HBV) is complex and involves both host innate and adaptive immune systems. It is well accepted that the development of sufficient HBV-specific T cell and B cell responses are required for controlling an HBV infection. However, the contribu...
Main Authors: | Zhiyong Ma, Qian Cao, Yong Xiong, Ejuan Zhang, Mengji Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-01-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | http://www.mdpi.com/2076-393X/6/1/6 |
Similar Items
-
Toll-like Receptor Response to Hepatitis C Virus Infection: A Recent Overview
by: Mohammad Enamul Hoque Kayesh, et al.
Published: (2022-05-01) -
Pre-Activation of Toll-Like Receptor 2 Enhances CD8+ T-Cell Responses and Accelerates Hepatitis B Virus Clearance in the Mouse Models
by: Yong Lin, et al.
Published: (2018-06-01) -
Toll-like receptor-mediated innate immunity orchestrates adaptive immune responses in HBV infection
by: Yanqin Du, et al.
Published: (2022-07-01) -
Toll-Like Receptors and the Response to Radiotherapy in Solid Tumors: Challenges and Opportunities
by: Ryma Haroun, et al.
Published: (2023-04-01) -
Toll-like Receptors and Prostate Cancer
by: Shu eZhao, et al.
Published: (2014-07-01)